<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <collab>PREVAIL II Writing Group</collab>
   <collab>Multi-National PREVAIL II Study Team</collab>
   <name>
    <surname>Davey</surname>
    <given-names>RT</given-names>
    <suffix>Jr</suffix>
   </name>
   <name>
    <surname>Dodd</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Proschan</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Neaton</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Neuhaus Nordwall</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Koopmeiners</surname>
    <given-names>JS</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A randomized, controlled trial of ZMapp for Ebola virus infection</article-title>
  <source>N Engl J Med</source>
  <year>2016</year>
  <volume>375</volume>
  <fpage>1448</fpage>
  <lpage>1456</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1604330</pub-id>
  <pub-id pub-id-type="pmid">27732819</pub-id>
 </element-citation>
</ref>
